Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
Roche Holding ROP1.53%increase; green up pointing triangle said it agreed to buy PathAI for up to $1.05 billion in a deal that seeks to bolster the artificial-intelligence offerings of its diagnostics ...
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiency Combining ...
Roche Holding AG expects to launch the breast cancer pill that may become one of its biggest sellers by the end of the year, sparking optimism about its prospects. The medicine, called giredestrant, ...
Roche Holding expects the obesity market to split into segments as weight-loss drugs reach the wider public, opening the door for new players to take on Eli Lilly and Novo Nordisk. “We are literally ...
Roche has ramped up its investment in NVIDIA's AI chips, launching an upscaled hybrid-cloud AI factory that it believes is the largest in the pharma industry. The Swiss group has bought 2,176 NVIDIA ...
It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...
A second phase 3 study of Roche’s fenebrutinib in relapsing multiple sclerosis (RMS) has hit its primary endpoint, positioning the company to submit the BTK inhibitor for approval. But the discovery ...
Among the various problems that hurt the New York Giants in their disappointing 4-13 season, it can't be stressed enough that they still have work to do to improve the interior defensive line and make ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Roche plans to launch Phase 3 ...
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced last week that it would more than triple its footprint in Harvard’s Enterprise Research Campus in Allston from ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results